We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sirtex Medical

News List

Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone prnasia
August 27, 2020
The notice confirms that SIR-Spheres® Y-90 resin microspheres meet the relevant requirements for drug registration in China. With this confirmation, Sirtex is approved to file a New Drug Application (NDA) in the country.
Sirtex Medical gets unsolicited $1.41B counteroffer from Chinese investment firm fiercebiotech
May 07, 2018
Sirtex Medical, an Australian biotech, received an unsolicited $1.41 billion counteroffer from Chinese fund manager CDH Investments.The counteroffer by CDH is a nonbinding, indicative and conditional proposal for 100%